EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 49 filers reported holding EVELO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $24,000 | -57.1% | 2,388 | -48.1% | 0.00% | – |
Q4 2020 | $56,000 | +460.0% | 4,597 | +138.3% | 0.00% | – |
Q3 2020 | $10,000 | -23.1% | 1,929 | -31.2% | 0.00% | – |
Q2 2020 | $13,000 | +116.7% | 2,803 | +59.4% | 0.00% | – |
Q1 2020 | $6,000 | -57.1% | 1,758 | -50.5% | 0.00% | – |
Q4 2019 | $14,000 | -51.7% | 3,553 | -26.2% | 0.00% | – |
Q3 2019 | $29,000 | -32.6% | 4,817 | -0.5% | 0.00% | – |
Q2 2019 | $43,000 | +65.4% | 4,841 | +46.9% | 0.00% | – |
Q1 2019 | $26,000 | -29.7% | 3,296 | +17.3% | 0.00% | – |
Q4 2018 | $37,000 | +311.1% | 2,811 | +247.9% | 0.00% | – |
Q3 2018 | $9,000 | – | 808 | +1823.8% | 0.00% | – |
Q2 2018 | $0 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |